Literature DB >> 17221058

GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma.

Joice Matos Biselli1, Renata Cristina de Angelo Calsaverini Leal, Mariângela Torreglosa Ruiz, Eny Maria Goloni-Bertollo, José Victor Maníglia, Andréa Regina Baptista Rossit, Erika Cristina Pavarino-Bertelli.   

Abstract

UNLABELLED: Gene variability related to carcinogen activation and detoxification may interfere with susceptibility to head and neck cancer. AIM: To investigate the relation between GSTT1 and GSTM1 null polymorphisms and the risk of head and neck squamous cell carcinoma in cigarette smokers. MATERIAL AND
METHOD: A case-control study conducted at the Sao Jose do Rio Preto Medical School, Brazil. GSTM1 and GSTT1 null genotype frequencies were evaluated by multiplex PCR in 45 cigarette smokers with head and neck squamous cell carcinomas and 45 cigarette smokers without this disease.
RESULTS: The oral cavity was the most prevalent tumor site for squamous cell carcinoma. The GSTT1 null genotype was found in 33.3% of the Experimental Group and 23.3% of the Control Group (p= 0.311). Experimental and Control Groups had GSTM1 null genotype frequencies of 35% and 48.3% (p=0.582). No association between alcohol consumption and GSTT1 and GSTMI null genotypes was found in these groups (p-values>0.05). There were more men, and alcohol consumption was prevalent in both groups.
CONCLUSION: In this study we were unable to show a correlation between GSTM1 and GSTT1 genotypes and the development of head and neck squamous cell carcinomas in cigarette smokers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17221058      PMCID: PMC9443562          DOI: 10.1016/s1808-8694(15)31022-3

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


  48 in total

1.  Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco.

Authors:  N Hamel; S Karimi; M N Hébert-Blouin; J S Brunet; B Gilfix; P Ghadirian; M J Black; S A Narod; W D Foulkes
Journal:  Int J Cancer       Date:  2000-08-01       Impact factor: 7.396

2.  Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population.

Authors:  Shama C Buch; Perin N Notani; Rajani A Bhisey
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

3.  Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers.

Authors:  Y J Hong; J K Lee; G H Lee; S I Hong
Journal:  Clin Chem Lab Med       Date:  2000-09       Impact factor: 3.694

4.  Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers.

Authors:  U J Nair; J Nair; B Mathew; H Bartsch
Journal:  Carcinogenesis       Date:  1999-05       Impact factor: 4.944

5.  Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.

Authors:  Charles G Minard; Margaret R Spitz; Xifeng Wu; Waun Ki Hong; Carol J Etzel
Journal:  Cancer       Date:  2006-06-15       Impact factor: 6.860

6.  Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.

Authors:  Michel B Oude Ophuis; Johannes J Manni; Wilber H M Peters
Journal:  Acta Otolaryngol       Date:  2006-03       Impact factor: 1.494

Review 7.  The pathology of oral cancer.

Authors:  D Murray Walker; George Boey; Louise A McDonald
Journal:  Pathology       Date:  2003-10       Impact factor: 5.306

8.  Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1.

Authors:  P J Sherratt; M M Manson; A M Thomson; E A Hissink; G E Neal; P J van Bladeren; T Green; J D Hayes
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.

Authors:  W A Anwar; S Z Abdel-Rahman; R A El-Zein; H M Mostafa; W W Au
Journal:  Carcinogenesis       Date:  1996-09       Impact factor: 4.944

10.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

View more
  9 in total

1.  Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.

Authors:  Javed Hussain Choudhury; Seram Anil Singh; Sharbadeb Kundu; Biswadeep Choudhury; Fazlur R Talukdar; Shilpee Srivasta; Ruhina S Laskar; Bishal Dhar; Raima Das; Shaheen Laskar; Manish Kumar; Wetetsho Kapfo; Rosy Mondal; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2015-02-28

2.  CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.

Authors:  Gustavo Jacob Lourenço; Erika Furquim Soledade Neves Silva; José Augusto Rinck-Junior; Carlos Takahiro Chone; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2011-08-26

3.  GSTM1 null polymorphisms is associated with laryngeal cancer risk: a meta-analysis.

Authors:  Yong Zhang; Wei Chen; Jun-feng Ji; Zhi-yi Wang; Ming-hai Wu; Kai Zhang; Qiu-ping Wang
Journal:  Tumour Biol       Date:  2014-03-19

4.  GSTM1 null genotype is a risk factor for laryngeal cancer.

Authors:  Xuejun Liu; Qijun Fan; Liyan Ni; Fanli Liu; Saiyu Huang; Jinjian Gao; Bobei Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Association between GSTP1, GSTM1 and GSTT1 polymorphisms involved in xenobiotic metabolism and head and neck cancer development.

Authors:  Anelise Russo; Pamela Risardi Francelin; Ana Lívia Silva Galbiatti; Luis Sérgio Raposo; José Victor Maníglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2013-05-10       Impact factor: 2.316

Review 6.  GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis.

Authors:  Fengying Zhang; Xijiang Wu; Jinming Niu; Xiufeng Kang; Liya Cheng; Yanchun Lv; Meimei Wu
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

7.  Differential Expression of Prostaglandin I2 Synthase Associated with Arachidonic Acid Pathway in the Oral Squamous Cell Carcinoma.

Authors:  Anelise Russo; Patrícia M Biselli-Chicote; Rosa S Kawasaki-Oyama; Márcia M U Castanhole-Nunes; José V Maniglia; Dalísio de Santi Neto; Érika C Pavarino; Eny M Goloni-Bertollo
Journal:  J Oncol       Date:  2018-11-08       Impact factor: 4.375

8.  Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.

Authors:  Leonor Varela-Lema; Emanuela Taioli; Alberto Ruano-Ravina; Juan M Barros-Dios; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Rajani A Bhisey; Gabriella Cadoni; Ettore Capoluongo; Chien-Jen Chen; William Foulkes; Eny Maria Goloni-Bertollo; Ana Hatagima; Richard B Hayes; Takahiko Katoh; Sergio Koifman; Phillip Lazarus; Johannes J Manni; Manoj Mahimkar; Shunji Morita; Jong Park; Kwang-Kyun Park; Erika Cristina Pavarino Bertelli; Enilze Maria de Souza Fonseca Ribeiro; Bidyut Roy; Margaret R Spitz; Richard C Strange; Qingyi Wei; Camille C Ragin
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822

9.  Association between GSTM1 and GSTT1 allelic variants and head and neck squamous cell cancinoma.

Authors:  Yang Zhang; Yuanyuan Ni; Hao Zhang; Yongchu Pan; Junqing Ma; Lin Wang
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.